1. Home
  2. LXU vs ANAB Comparison

LXU vs ANAB Comparison

Compare LXU & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$13.82

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$70.31

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXU
ANAB
Founded
1968
2005
Country
United States
United States
Employees
513
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
LXU
ANAB
Price
$13.82
$70.31
Analyst Decision
Hold
Buy
Analyst Count
4
11
Target Price
$14.63
$74.64
AVG Volume (30 Days)
1.9M
553.9K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
225.93
91.02
EPS
0.34
N/A
Revenue
$615,208,000.00
$234,603,000.00
Revenue This Year
$10.78
N/A
Revenue Next Year
N/A
$31.11
P/E Ratio
$41.94
N/A
Revenue Growth
17.77
157.01
52 Week Low
$4.92
$17.11
52 Week High
$17.22
$73.30

Technical Indicators

Market Signals
Indicator
LXU
ANAB
Relative Strength Index (RSI) 47.51 65.81
Support Level $7.88 $53.46
Resistance Level $15.66 N/A
Average True Range (ATR) 0.99 4.40
MACD -0.33 0.83
Stochastic Oscillator 17.29 84.92

Price Performance

Historical Comparison
LXU
ANAB

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: